These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36434579)

  • 1. Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach.
    Passero L; Srinivasan S; Grewe ME; Leeman J; Berg J; Reuland D; Roberts MC
    BMC Health Serv Res; 2022 Nov; 22(1):1411. PubMed ID: 36434579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for Lynch syndrome cascade testing in the United States.
    Passero LE; Roberts MC
    Fam Cancer; 2024 Jun; 23(2):147-154. PubMed ID: 38548925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.
    Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC
    Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
    Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
    Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Hall MJ
    J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.
    Petersen J; Koptiuch C; Wu YP; Mooney R; Elrick A; Szczotka K; Keener M; Pappas L; Kanth P; Soisson A; Kohlmann W; Kaphingst KA
    Patient Educ Couns; 2018 Nov; 101(11):2011-2017. PubMed ID: 30097381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
    Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
    Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
    Giardiello FM; Allen JI; Axilbund JE; Boland CR; Burke CA; Burt RW; Church JM; Dominitz JA; Johnson DA; Kaltenbach T; Levin TR; Lieberman DA; Robertson DJ; Syngal S; Rex DK
    Am J Gastroenterol; 2014 Aug; 109(8):1159-79. PubMed ID: 25070057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
    Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
    Sharaf RN; Myer P; Stave CD; Diamond LC; Ladabaum U
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1093-100. PubMed ID: 23669308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leadership perspectives on key elements influencing implementing a family-focused intervention in mental health services.
    Allchin B; Goodyear M; O'Hanlon B; Weimand BM
    J Psychiatr Ment Health Nurs; 2020 Oct; 27(5):616-627. PubMed ID: 32037644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
    Meyer LA; Broaddus RR; Lu KH
    Cancer Control; 2009 Jan; 16(1):14-22. PubMed ID: 19078925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
    Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
    Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
    De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
    J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.